author

ActiveCampaign’s Free Trial: Experience AI-Powered Marketing Automation Before You Commit

Most marketing platforms promise automation. In practice, what they deliver is a glorified email scheduler with a few if-then rules bolted on. ActiveCampaign is one of the few tools where the automation actually lives up to the branding, and right now you can test the full platform free for 14 days with no credit card […]

This story continues at The Next Web

Keith raises £2M to become the UK’s most automated law firm

Andy Shovel and Pete Sharman, who built THIS into a market-leading plant-based food brand, are pivoting hard. Keith is an AI-native regulated law firm targeting conveyancing first, with a 24/7 AI client agent and a target of reducing transaction times by 70%. Launch is Q3 2026. Andy Shovel’s previous company sold plant-based bacon and chicken. […]

This story continues at The Next Web

Princess Nourah bint Abdulrahman University Selects Medad Admission Platform

Princess Nourah bint Abdulrahman University has partnered with Naseej for Technology to implement Medad Admission Platform, a cloud-based Saas platform that integrates with internal and external entities, fully automating the admission process at the Deanship of Admission and Registration.

The post Princess Nourah bint Abdulrahman University Chooses Medad Admission Platform appeared first on Naseej For Technology.

OpenAI Invests in a Nine-Month-Old Startup Creating AI Agent Swarms with a $650 Million Valuation

Isara, a San Francisco startup that is building software to coordinate thousands of AI agents on complex analytical tasks, has raised $94 million at a $650 million valuation, with OpenAI among the investors. The company was founded nine months ago by two 23-year-olds. It has no product in market. The round was first reported by […]

This story continues at The Next Web

Ysios Capital Launches €100M Fund to Build Biotech Companies from Spanish Science

Spain’s largest life sciences VC is moving upstream with InceptionBio, its first fund dedicated to the riskiest stage of biotech: company creation from university and research centre spinouts. CDTI is an anchor LP. The target is at least three new companies in 2026. The hardest part of turning academic science into a biotech company is […]

This story continues at The Next Web